Trigger Point Pain, MyofascialKinesioTapeNCT06012305
The Effect of KT on Tissue Parameters
A study testing Taping in people with Trigger Point Pain, Myofascial, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).
Trial summary
Myofascial pain is a concept that refers to pain from trigger points. The region of the upper trapezius muscle is the most common region of myofascial pain syndrome (MAS). It is known that MAS is associated with disruptions in the fascia. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Trigger Point Pain, Myofascial
- What is being tested?
- Taping
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Feb 2024to 1 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Patients with a differential diagnosis of myofascial pain syndrome with unilateral or bilateral active trigger points in the upper trapezius muscle will be included in the study. The criteria for trigger point detection are stated in the literature as follows: 1) The muscle has a challenging palpation area (this area is called the taut band) 2) The trigger point with localized sensitivity in the taut band 3) Typical pain when continuous pressure is applied to the trigger point in the taut band. , numbness, tingling, 4) Local twitching response when the taut band is bent horizontally. Other inclusion criteria are: 18-50 years of age, more than two weeks of symptom duration
Who cannot join
- Having a diagnosis of fibromyalgia syndrome, diagnosis of psychiatric disorders such as anxiety and depression, radiculopathy symptoms, brachial plexopathy or other nerve entrapments, treatment for myofascial pain syndrome in the last six months, having a malignancy, being pregnant, having an infectious disease, having an inflammatory musculoskeletal system disease have had shoulder or neck surgery
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Tokat Gaziosmanpaşa University
Tokat Province, Eyalet/Yerleşke, 06300
About this study
Official title: The Effect of Different KT Applications on Tissue Stiffness, Pain and Function
Myofascial pain is a concept that refers to pain from trigger points. The region of the upper trapezius muscle is the most common region of myofascial pain syndrome (MAS). It is known that MAS is associated with disruptions in the fascia. It has been observed that kinesio taping supports healing by increasing the epidermal dermal distance. It is thought that the EDF (Epidermis Dermis Fascia) technique provides this effect on the fascia. This idea needs to be put forward with objective data and the study was designed for this purpose. It has been observed that kinesio taping with the inhibition technique for the upper trapezius trigger point has a positive effect on pain and function. Therefore, it will be investigated whether the EDF technique and the inhibition technique have any advantages over each other. An exercise program will be applied to all three groups in the study design, so whether taping provides an additional benefit to fascia smoothness, pain and function will be examined and the 4-week long-term effect of taping, which is mostly short-term effect, will be revealed.
Read the detailed description
Myofascial pain is a concept that refers to pain from myofascial trigger points. Certain small, hardened, tender areas in the muscle that can be identified by palpation are called trigger points. The upper trapezius is the most common area of myofascial pain syndrome. Working at a desk for a long time and doing intense overhead activities are among the important reasons for this. Individuals who experience myofascial pain with an upper trapezius trigger point are adversely affected in many ways professionally and socially. The pathophysiological process that causes this pain is also related to fascia involvement. It is thought that a taping application that will provide a corrective effect on the fascia will reduce myofascial pain symptoms. The study was designed with the aim of demonstrating that it provides this with objective data.
Kinesio taping increases the epidermal-dermal distance and provides an effect that accelerates the healing after injury. It has been widely preferred in our country and in other countries before, and there is literature support that it can be used safely. It is seen that the inhibition technique is frequently preferred when taping is used in the presence of an upper trapezius trigger point. It is thought that trigger point symptoms will be reduced by inhibiting the upper trapezius muscle to a certain extent with this technique, and some studies in which this effect is achieved are included in the literature. Another taping technique, the Epidermis Dermis Fascia technique (EDF), has been reported to have a healing effect on fascia as clinical opinion, but there is a lack of evidence in the relevant literature.
At the end of the study, the answers to the questions of whether the inhibition technique, which is one of the frequently used techniques, or the epidermis dermis fascia technique, which is at the forefront with its effect on fascia, will be more effective on fascia smoothness, pain and function will be found. With the provision of fascia correction, it is aimed to reduce pain and increase function. It is thought that these gains will reduce the negative effects of myofascial pain.
In addition to taping, two groups will be given an exercise program with proven effect of reducing pain and increasing function in myofascial pain syndrome. The program will include ischemic compression and posture exercises.
The aspects that have not been revealed in previous studies and are considered to be deficiencies are as follows: Which tape technique should be used, which one can be more beneficial? In which of the parameters of pain, function and fascia smoothness will the benefit be valid? What is the long-term effect of kinesio taping, which has a pain-reducing and function-enhancing effect in the short term?
- Conditions
- Trigger Point Pain, Myofascial
- Being tested
- Taping
- Keywords
- Athletic Tape, Trigger Points
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TapingOther
Also called Exercise, ischemic compression
Taping has the effect of accelerating the flow in the tissue by increasing the epidermal dermal distance. The muscle technique used in the study will be applied to the trapezius muscle and aims to reduce the working level of the muscle. The EDF technique, which will be used in another group, aims to create a stronger base taping effect.
| Study group | Role | What they receive |
|---|---|---|
| Only Exercise Group | No intervention | They will be included in the exercise program that includes postural exercises after ischemic compression and stretching. Stretching exercises will be aimed at stretching the upper trapezius muscle. In the sitting position, the person whose head will be flexed and lateral flexed to the opposite side will stay in this position for 30 seconds and then come back to the same position. This will be practiced 15 times a day, 3 days a week. Ischemic compression will then be applied. In ischemic compression, the therapist will apply pressure on the trigger points detected by palpation for 1 minute, and the application will be completed with a total of 5 repetitions at 1-minute intervals. It will continue to be applied 3 sets a day, 3 days a week. Posture exercises were determined as scapular retraction and chin tuck exercises. The exercises will be done in 3 sets of 15 repetitions per day, 3 days a week. |
| Taping Group with Muscle Technique | Active comparator | In addition to the exercise program in the first group, upper trapezius inhibition tape will be applied on the myofascial trigger points in the upper trapezius 3 times a week. The KT (Kinesio Tex Tape, Kinesio Holding Corporation, Albuquerque, USA) used in this study will be waterproof, porous and adhesive. 5 cm wide and 0.5 mm thick kinesio tape will be used. Before the application, the patient will be seated and asked to bring the neck to the opposite side lateral flexion and the head to the same side rotation. In this position, the Kinesiotape inhibition technique will be applied. The tape will be asked to stay on the person for 2 days, then it will be interrupted for 1 day and then the same application will be made. This practice will continue during the 4 weeks of treatment. Receives: Other: Taping |
| Taping Group with Epidermis Dermis Fascia Technique | Experimental | In addition to the exercise program in the first group, kinesio taping will be applied with web cut cutting with EDF technique on myofascial trigger points in the upper trapezius. Before the application, the patient will be seated and asked to bring the neck to the opposite side lateral flexion and the head to the same side rotation. Tape will be applied with EDF technique. The band will be asked to stay on the person for 2 days, then a break for 1 day and then the same application will be made again. This practice will continue during the 4 weeks of treatment. Receives: Other: Taping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of fascia stiffness by shear wave elastography
The device provides information on hardness by measuring the velocity of shear waves. The transducer probe of the device will be placed on the tight band in the upper trapezius detected by palpation, and after a comfortable expiration, an image will be taken from the region while the person is sitting. It is planned to take 3 images at 10 second intervals. The acquired image presents both quantitative and qualitative data. Shear modulus values of 10x10 mm square images taken on the trigger point will provide objective data on hardness.
Measured: Three measurements at once at the beginning and end of 4 weeks, measurement time 5 minutes per session
Secondary outcomes (4)
Measurement of pain pressure threshold with an algometer
An analog algometer will be used. The device has a disc-shaped rubber tip with a surface area of exactly 1 cm2. Pressure measurements are expressed in kilograms per square centimeter (kg/cm2). Algometer, metal rod will be perpendicular to the skin surface and the patient will sit; Pressure will be applied to the determined trigger point in 1 kg/second increments. The patient will be instructed to indicate the last point at which pain was perceived. After the dial is set to zero, the process will be repeated 3 times for each patient at 1 minute intervals. The average of three readings will be used for analysis. The dial will show a value between 0 and 22. 0 represents the lowest point of the pain threshold, 22 the highest point.
Measured: Three measurements at once at the beginning and end of 4 weeks, measurement time 5 minutes per session
Pain Assessment with Visual Analog Scale
It will be used in two separate pain evaluations for the upper trapezius region and the pain radiating to the neck and back. 0 will indicate no pain, and ten will show the worst pain the patient has ever experienced. Values will be obtained along a 10 cm Visual Analog Scale line using a ruler marked in centimeters.
Measured: One measurement at the beginning and end of 4 weeks, 30 seconds measurement time per session
Evaluation of upper extremity functions
The short version of the Arm, Shoulder, and Hand Problems Questionnaire(DASH) will be used to make this assessment. DASH is a 30-item questionnaire designed to assess musculoskeletal disorders of the upper extremities. At least 27 questions must be completed for scoring. DASH scores range from 0 to 100, with higher scores indicating a higher level of disability. DASH has been reported to be a valid and reliable tool for evaluating various arm functions. There is information in the literature that Quick DASH, which is its short version, can also provide information about upper extremity function in correlation with DASH. Turkish validity and reliability study was conducted.
Measured: The questionnaire will be administered at the beginning and end of 4 weeks. The application time of the questionnaire is approximately 5 minutes.
Neck Disability Index
Vernon and Mion designed the Neck Disability Index (NDI) to assess how neck pain affects activities of daily living. There is a Turkish validity and reliability study. A score between 0 and 50 points can be obtained from the scale. 0 points means no disability, 50 points means very severe disability.
Measured: The questionnaire will be administered at the beginning and end of 4 weeks. The application time of the questionnaire is approximately 5 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Aug 2023
- Study start10 Feb 2024
- Primary completion15 Jul 2024
- Study completion1 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Trigger Point Pain, MyofascialStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- In the study, there were three groups in which three different treatment programs were applied.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tokat Gaziosmanpasa University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nilsah YILMAZ, Tokat Gaziosmanpasa University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06012305
- Sponsor's protocol ID
- GaziosmanpasaU-FTR
- Acronym
- KinesioTape
- Status last verified
- Aug 2026
- First submitted
- 17 Aug 2023
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Quintner JL, Bove GM, Cohen ML. A critical evaluation of the trigger point phenomenon. Rheumatology (Oxford). 2015 Mar;54(3):392-9. doi: 10.1093/rheumatology/keu471. Epub 2014 Dec 3.
PubMed 25477053Ertekin E, Kasar ZS, Turkdogan FT. Is early diagnosis of myofascial pain syndrome possible with the detection of latent trigger points by shear wave elastography? Pol J Radiol. 2021 Jul 12;86:e425-e431. doi: 10.5114/pjr.2021.108537. eCollection 2021.
PubMed 34429789Celiker R, Atalay A, Guven Z. Health-related quality of life in patients with myofascial pain syndrome. Curr Pain Headache Rep. 2010 Oct;14(5):361-6. doi: 10.1007/s11916-010-0141-7.
PubMed 20690001Kafa N, Citaker S, Omeroglu S, Peker T, Coskun N, Diker S. Effects of kinesiologic taping on epidermal-dermal distance, pain, edema and inflammation after experimentally induced soft tissue trauma. Physiother Theory Pract. 2015;31(8):556-61. doi: 10.3109/09593985.2015.1062943.
PubMed 26492435Akpinar FM, Sindel D, Ketenci A. Investigation of Effectiveness of Two Different Kinesiotaping Techniques in Myofascial Pain Syndrome: An Open-Label Randomized Clinical Trial. Pain Physician. 2021 Sep;24(6):E721-E731.
PubMed 34554690Dilek B, Batmaz I, Akif Sariyildiz M, Sahin E, Bulut D, Akalin E, Cevik R, Nas K. Effectiveness of training about kinesiotaping in myofascial pain syndrome: A prospective, single-blind, randomized-controlled study. Turk J Phys Med Rehabil. 2021 Mar 4;67(1):17-24. doi: 10.5606/tftrd.2021.4258. eCollection 2021 Mar.
PubMed 33948539
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Different KT Applications on Tissue Stiffness, Pain and Function
- ClinicalTrials.gov ID
- NCT06012305
- Acronym / sponsor ID
- KinesioTape / GaziosmanpasaU-FTR
- Conditions
- Trigger Point Pain, Myofascial
- Keywords
- Athletic Tape, Trigger Points
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Tokat Gaziosmanpasa UniversityUniversity, hospital or other
- Study start
- 10 Feb 2024 (actual)
- Primary completion
- 15 Jul 2024 (actual)
- Study completion
- 1 Sep 2024 (actual)
- First posted
- 25 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Myofascial pain is a concept that refers to pain from trigger points. The region of the upper trapezius muscle is the most common region of myofascial pain syndrome (MAS). It is known that MAS is associated with disruptions in the fascia. It has been observed that kinesio taping supports healing by increasing the epidermal dermal distance. It is thought that the EDF (Epidermis Dermis Fascia) technique provides this effect on the fascia. This idea needs to be put forward with objective data and the study was designed for this purpose. It has been observed that kinesio taping with the inhibition technique for the upper trapezius trigger point has a positive effect on pain and function. Therefore, it will be investigated whether the EDF technique and the inhibition technique have any advantages over each other. An exercise program will be applied to all three groups in the study design, so whether taping provides an additional benefit to fascia smoothness, pain and function will be examined and the 4-week long-term effect of taping, which is mostly short-term effect, will be revealed.
Detailed description
Myofascial pain is a concept that refers to pain from myofascial trigger points. Certain small, hardened, tender areas in the muscle that can be identified by palpation are called trigger points. The upper trapezius is the most common area of myofascial pain syndrome. Working at a desk for a long time and doing intense overhead activities are among the important reasons for this. Individuals who experience myofascial pain with an upper trapezius trigger point are adversely affected in many ways professionally and socially. The pathophysiological process that causes this pain is also related to fascia involvement. It is thought that a taping application that will provide a corrective effect on the fascia will reduce myofascial pain symptoms. The study was designed with the aim of demonstrating that it provides this with objective data.
Kinesio taping increases the epidermal-dermal distance and provides an effect that accelerates the healing after injury. It has been widely preferred in our country and in other countries before, and there is literature support that it can be used safely. It is seen that the inhibition technique is frequently preferred when taping is used in the presence of an upper trapezius trigger point. It is thought that trigger point symptoms will be reduced by inhibiting the upper trapezius muscle to a certain extent with this technique, and some studies in which this effect is achieved are included in the literature. Another taping technique, the Epidermis Dermis Fascia technique (EDF), has been reported to have a healing effect on fascia as clinical opinion, but there is a lack of evidence in the relevant literature.
At the end of the study, the answers to the questions of whether the inhibition technique, which is one of the frequently used techniques, or the epidermis dermis fascia technique, which is at the forefront with its effect on fascia, will be more effective on fascia smoothness, pain and function will be found. With the provision of fascia correction, it is aimed to reduce pain and increase function. It is thought that these gains will reduce the negative effects of myofascial pain.
In addition to taping, two groups will be given an exercise program with proven effect of reducing pain and increasing function in myofascial pain syndrome. The program will include ischemic compression and posture exercises.
The aspects that have not been revealed in previous studies and are considered to be deficiencies are as follows: Which tape technique should be used, which one can be more beneficial? In which of the parameters of pain, function and fascia smoothness will the benefit be valid? What is the long-term effect of kinesio taping, which has a pain-reducing and function-enhancing effect in the short term?
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- In the study, there were three groups in which three different treatment programs were applied.
| Arm | Type | Receives |
|---|---|---|
| Only Exercise Group | No intervention | –They will be included in the exercise program that includes postural exercises after ischemic compression and stretching. Stretching exercises will be aimed at stretching the upper trapezius muscle. In the sitting position, the person whose head will be flexed and lateral flexed to the opposite side will stay in this position for 30 seconds and then come back to the same position. This will be practiced 15 times a day, 3 days a week. Ischemic compression will then be applied. In ischemic compression, the therapist will apply pressure on the trigger points detected by palpation for 1 minute, and the application will be completed with a total of 5 repetitions at 1-minute intervals. It will continue to be applied 3 sets a day, 3 days a week. Posture exercises were determined as scapular retraction and chin tuck exercises. The exercises will be done in 3 sets of 15 repetitions per day, 3 days a week. |
| Taping Group with Muscle Technique | Active comparator | Other: TapingIn addition to the exercise program in the first group, upper trapezius inhibition tape will be applied on the myofascial trigger points in the upper trapezius 3 times a week. The KT (Kinesio Tex Tape, Kinesio Holding Corporation, Albuquerque, USA) used in this study will be waterproof, porous and adhesive. 5 cm wide and 0.5 mm thick kinesio tape will be used. Before the application, the patient will be seated and asked to bring the neck to the opposite side lateral flexion and the head to the same side rotation. In this position, the Kinesiotape inhibition technique will be applied. The tape will be asked to stay on the person for 2 days, then it will be interrupted for 1 day and then the same application will be made. This practice will continue during the 4 weeks of treatment. |
| Taping Group with Epidermis Dermis Fascia Technique | Experimental | Other: TapingIn addition to the exercise program in the first group, kinesio taping will be applied with web cut cutting with EDF technique on myofascial trigger points in the upper trapezius. Before the application, the patient will be seated and asked to bring the neck to the opposite side lateral flexion and the head to the same side rotation. Tape will be applied with EDF technique. The band will be asked to stay on the person for 2 days, then a break for 1 day and then the same application will be made again. This practice will continue during the 4 weeks of treatment. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Patients with a differential diagnosis of myofascial pain syndrome with unilateral or bilateral active trigger points in the upper trapezius muscle will be included in the study. The criteria for trigger point detection are stated in the literature as follows: 1) The muscle has a challenging palpation area (this area is called the taut band) 2) The trigger point with localized sensitivity in the taut band 3) Typical pain when continuous pressure is applied to the trigger point in the taut band. , numbness, tingling, 4) Local twitching response when the taut band is bent horizontally. Other inclusion criteria are: 18-50 years of age, more than two weeks of symptom duration
Key exclusion criteria (1 listed)
- Having a diagnosis of fibromyalgia syndrome, diagnosis of psychiatric disorders such as anxiety and depression, radiculopathy symptoms, brachial plexopathy or other nerve entrapments, treatment for myofascial pain syndrome in the last six months, having a malignancy, being pregnant, having an infectious disease, having an inflammatory musculoskeletal system disease have had shoulder or neck surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TapingAlso: Exercise, ischemic compressionTaping has the effect of accelerating the flow in the tissue by increasing the epidermal dermal distance. The muscle technique used in the study will be applied to the trapezius muscle and aims to reduce the working level of the muscle. The EDF technique, which will be used in another group, aims to create a stronger base taping effect. | Other | Taping Group with Epidermis Dermis Fascia Technique, Taping Group with Muscle Technique |
Primary outcome
Evaluation of fascia stiffness by shear wave elastography
Time frame: Three measurements at once at the beginning and end of 4 weeks, measurement time 5 minutes per session
The device provides information on hardness by measuring the velocity of shear waves. The transducer probe of the device will be placed on the tight band in the upper trapezius detected by palpation, and after a comfortable expiration, an image will be taken from the region while the person is sitting. It is planned to take 3 images at 10 second intervals. The acquired image presents both quantitative and qualitative data. Shear modulus values of 10x10 mm square images taken on the trigger point will provide objective data on hardness.
4 secondary outcomes
Measurement of pain pressure threshold with an algometer
Time frame: Three measurements at once at the beginning and end of 4 weeks, measurement time 5 minutes per session
Pain Assessment with Visual Analog Scale
Time frame: One measurement at the beginning and end of 4 weeks, 30 seconds measurement time per session
Evaluation of upper extremity functions
Time frame: The questionnaire will be administered at the beginning and end of 4 weeks. The application time of the questionnaire is approximately 5 minutes.
Neck Disability Index
Time frame: The questionnaire will be administered at the beginning and end of 4 weeks. The application time of the questionnaire is approximately 5 minutes.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Results publication: PubMed 25477053Quintner JL, Bove GM, Cohen ML. A critical evaluation of the trigger point phenomenon. Rheumatology (Oxford). 2015 Mar;54(3):392-9. doi: 10.1093/rheumatology/keu471. Epub 2014 Dec 3.
- Results publication: PubMed 34429789Ertekin E, Kasar ZS, Turkdogan FT. Is early diagnosis of myofascial pain syndrome possible with the detection of latent trigger points by shear wave elastography? Pol J Radiol. 2021 Jul 12;86:e425-e431. doi: 10.5114/pjr.2021.108537. eCollection 2021.
- Results publication: PubMed 20690001Celiker R, Atalay A, Guven Z. Health-related quality of life in patients with myofascial pain syndrome. Curr Pain Headache Rep. 2010 Oct;14(5):361-6. doi: 10.1007/s11916-010-0141-7.
- Results publication: PubMed 26492435Kafa N, Citaker S, Omeroglu S, Peker T, Coskun N, Diker S. Effects of kinesiologic taping on epidermal-dermal distance, pain, edema and inflammation after experimentally induced soft tissue trauma. Physiother Theory Pract. 2015;31(8):556-61. doi: 10.3109/09593985.2015.1062943.
- Results publication: PubMed 34554690Akpinar FM, Sindel D, Ketenci A. Investigation of Effectiveness of Two Different Kinesiotaping Techniques in Myofascial Pain Syndrome: An Open-Label Randomized Clinical Trial. Pain Physician. 2021 Sep;24(6):E721-E731.
- Results publication: PubMed 33948539Dilek B, Batmaz I, Akif Sariyildiz M, Sahin E, Bulut D, Akalin E, Cevik R, Nas K. Effectiveness of training about kinesiotaping in myofascial pain syndrome: A prospective, single-blind, randomized-controlled study. Turk J Phys Med Rehabil. 2021 Mar 4;67(1):17-24. doi: 10.5606/tftrd.2021.4258. eCollection 2021 Mar.
- Individual participant dataSharing planned: No
Related trials for Trigger Point Pain, Myofascial
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Not yet recruiting
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Myofacial Pain Syndrome, Chronic Neck Pain
Recruiting
Comparing Myofascial Exercise and Trigger Point Therapy for Non-Specific Low Back Pain
Non-specific Low Back Pain
Not yet recruitingPhase 4
Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia
Myofascial Pain Syndrome (MPS)
Not yet recruiting
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With Mechanical Neck Pain and Forward Head Posture
Myofascial Trigger Points, Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Taping in people with Trigger Point Pain, Myofascial, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of fascia stiffness by shear wave elastography (time frame: Three measurements at once at the beginning and end of 4 weeks, measurement time 5 minutes per session). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06012305, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.